From lab to factory floor: ChemT nets US$4M to make cell therapies easier to manufacture
ChemT Biotechnology, a US‑Singapore startup that claims it has built an “intelligence layer” for bio-manufacturing, has raised a total of US$5 million in 18 months, including a US$4 million seed round led by Wavemaker Ventures and co‑investment partner SEEDS. The company, which combines machine…
No discussion yet. Be the first to share your thoughts!